2.84
price up icon2.16%   0.06
after-market アフターアワーズ: 2.85 0.01 +0.35%
loading
前日終値:
$2.78
開ける:
$2.82
24時間の取引高:
118.71K
Relative Volume:
1.67
時価総額:
$3.97M
収益:
-
当期純損益:
$-12.30M
株価収益率:
-0.4416
EPS:
-6.4313
ネットキャッシュフロー:
$-11.13M
1週間 パフォーマンス:
-16.10%
1か月 パフォーマンス:
-17.20%
6か月 パフォーマンス:
-63.31%
1年 パフォーマンス:
-67.07%
1日の値動き範囲:
Value
$2.72
$3.22
1週間の範囲:
Value
$2.18
$3.4355
52週間の値動き範囲:
Value
$2.18
$22.35

Palisade Bio Inc Stock (PALI) Company Profile

Name
名前
Palisade Bio Inc
Name
セクター
Healthcare (1181)
Name
電話
(858) 704-4900
Name
住所
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Name
職員
9
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
PALI's Discussions on Twitter

Palisade Bio Inc (PALI) 最新ニュース

pulisher
Nov 04, 2024

Palisade Bio (NASDAQ:PALI) and Allogene Therapeutics (NASDAQ:ALLO) Critical Survey - Defense World

Nov 04, 2024
pulisher
Oct 31, 2024

Palisade Bio advances novel IBD treatment PALI-2108 - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Palisade Bio advances novel IBD treatment PALI-2108 By Investing.com - Investing.com UK

Oct 31, 2024
pulisher
Oct 31, 2024

HYCU® Recognized as CRN 2024 Product of the Year Finalist - The Manila Times

Oct 31, 2024
pulisher
Oct 31, 2024

Palisade Bio Announces Positive Data from Two Ex Vivo - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Palisade Bio Announces Positive Data from Two Ex Vivo Translational Studies of PALI-2108 for the Treatment of Ulcerative Colitis - StockTitan

Oct 31, 2024
pulisher
Oct 30, 2024

PALI stock touches 52-week low at $3.09 amid market fluctuations - Investing.com

Oct 30, 2024
pulisher
Oct 24, 2024

Alto Neuroscience’s Depression Trial Failure Sends Shares Into Downward Spiral - MedCity News

Oct 24, 2024
pulisher
Oct 15, 2024

Palisade Bio Announces Abstract Accepted for Presentation - GlobeNewswire

Oct 15, 2024
pulisher
Oct 15, 2024

Palisade Bio Announces Abstract Accepted for Presentation at the American College of Gastroenterology's (ACG) 2024 Annual Scientific Meeting - The Manila Times

Oct 15, 2024
pulisher
Oct 12, 2024

Sutro Biopharma (NASDAQ:STRO) & Palisade Bio (NASDAQ:PALI) Head-To-Head Contrast - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

Meta Platforms (NASDAQ:META) Shares Up 0.6% Following Analyst Upgrade - Defense World

Oct 12, 2024
pulisher
Oct 11, 2024

Palisade Bio receives Health Canada nod for UC drug trial By Investing.com - Investing.com Australia

Oct 11, 2024
pulisher
Oct 10, 2024

Palisade Bio receives Health Canada nod for UC drug trial - Investing.com

Oct 10, 2024
pulisher
Oct 10, 2024

Palisade Bio Cleared by Health Canada to Commence Phase 1 - GlobeNewswire

Oct 10, 2024
pulisher
Oct 10, 2024

Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC) - Yahoo Finance

Oct 10, 2024
pulisher
Oct 08, 2024

Palisade Bio to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC - The Manila Times

Oct 08, 2024
pulisher
Sep 28, 2024

Palisade Bio, Inc. (NASDAQ:PALI) Shares Sold by Armistice Capital LLC - Defense World

Sep 28, 2024
pulisher
Sep 28, 2024

Palisade Bio inks new deal with CEO Finley; terms disclosed By Investing.com - Investing.com Canada

Sep 28, 2024
pulisher
Sep 28, 2024

Palisade Bio inks new deal with CEO Finley; terms disclosed - Investing.com India

Sep 28, 2024
pulisher
Sep 27, 2024

Palisade Bio CEO Finley’s Revised Employment and Compensation Deal - TipRanks

Sep 27, 2024
pulisher
Sep 26, 2024

Palisade submits CTA for PDE4 inhibitor prodrug for ulcerative colitis - BioWorld Online

Sep 26, 2024
pulisher
Sep 25, 2024

PALI stock touches 52-week low at $3.3 amid market fluctuations - Investing.com UK

Sep 25, 2024
pulisher
Sep 25, 2024

PALIPalisade Bio, Inc. Latest Stock News & Market Updates - StockTitan

Sep 25, 2024
pulisher
Sep 25, 2024

Palisade Bio Provides Update on Progress Toward Launch of - GlobeNewswire

Sep 25, 2024
pulisher
Sep 25, 2024

Palisade Bio Provides Update on Progress Toward Launch of Phase 1 Human Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis - StockTitan

Sep 25, 2024
pulisher
Sep 24, 2024

Klea Holding Evaluates Generous Takeover Offer - TipRanks

Sep 24, 2024
pulisher
Sep 23, 2024

The growth track for Kura Oncology Inc (KURA) has changed recently - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Potential Price Increase for Kulicke & Soffa Industries, Inc. (KLIC) After Recent Insider Activity - Knox Daily

Sep 23, 2024
pulisher
Sep 22, 2024

Big Changes At Disney Animation: Jennifer Lee Steps Down And Jared Bush Steps In - mxdwn.com

Sep 22, 2024
pulisher
Sep 22, 2024

116,268 Shares in Proficient Auto Logistics, Inc. (NASDAQ:PAL) Purchased by First Eagle Investment Management LLC - MarketBeat

Sep 22, 2024
pulisher
Sep 21, 2024

Angelina Jolie overwhelmed by ‘beautiful feeling’ of motherhood - FemaleFirst

Sep 21, 2024
pulisher
Sep 20, 2024

Anitra (AMEX:AZTR) Stock Quotes, Forecast and News Summary - Benzinga

Sep 20, 2024
pulisher
Sep 20, 2024

Palisade Bio (NASDAQ:PALI) Stock Quotes, Forecast and News Summary - Benzinga

Sep 20, 2024
pulisher
Sep 20, 2024

Proficient Auto Logistics (NASDAQ:PAL) Earns "Outperform" Rating from Barrington Research - MarketBeat

Sep 20, 2024
pulisher
Sep 19, 2024

Jared Bush Taking Over Jennifer Lee’s Role As Walt Disney Animation Studios Chief Creative Officer - What's On Disney Plus

Sep 19, 2024
pulisher
Sep 18, 2024

Alaska Air completes acquisition of Hawaiian Airlines - The Seattle Times

Sep 18, 2024
pulisher
Sep 18, 2024

Bokf Na Has $58,000 Stock Position in Haleon plc (NYSE:HLN) - Defense World

Sep 18, 2024
pulisher
Sep 16, 2024

CERo Therapeutics Hldgs (NASDAQ:CERO) Stock Quotes, Forecast and News Summary - Benzinga

Sep 16, 2024
pulisher
Sep 16, 2024

Palisade Bio Launches New Corporate Branding and Reiterates Commitment to Advancing Next-Generation Precision Therapies - StockTitan

Sep 16, 2024
pulisher
Sep 16, 2024

Palisade Bio Launches New Corporate Branding and Reiterates - GlobeNewswire

Sep 16, 2024
pulisher
Sep 13, 2024

Sonnet BioTherapeutics (NASDAQ:SONN) Stock Quotes, Forecast and News Summary - Benzinga

Sep 13, 2024
pulisher
Sep 11, 2024

Why Palisade Bio Stock Is Soaring Today - MSN

Sep 11, 2024
pulisher
Sep 05, 2024

Palisade Bio advances ulcerative colitis treatment - Investing.com

Sep 05, 2024
pulisher
Sep 05, 2024

Palisade Bio Reports Data Demonstrating PDE4B Expression in - GlobeNewswire

Sep 05, 2024
pulisher
Sep 05, 2024

Palisade Bio Reports Data Demonstrating PDE4B Expression in Patient Cohorts Could be Utilized as a Potential Marker for Patient Stratification - Yahoo Finance

Sep 05, 2024
pulisher
Sep 03, 2024

Arrowhead chases Ionis in rare, genetic disease race - BioWorld Online

Sep 03, 2024
pulisher
Aug 29, 2024

Palisade Bio (NASDAQ:PALI) Trading 3.2% Higher - Defense World

Aug 29, 2024
pulisher
Aug 21, 2024

Palisade Bio Edges up on Q2 Results - MSN

Aug 21, 2024
pulisher
Aug 21, 2024

Arrowhead Pharmaceuticals to Present New Phase 3 Data at ESC 2024 from PALISADE Study of Plozasiran in Patients with Familial Chylomicronemia Syndrome - Business Wire

Aug 21, 2024
pulisher
Aug 19, 2024

Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Aug 19, 2024

Palisade Bio Inc (PALI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):